Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183651 · ClinicalTrials.gov registry record · Phase 2
Treatment of Suicidal Women With Borderline Personality Disorder
A Phase 2 study of Suicide and Borderline Personality Disorder, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT00183651 is a Phase 2 study of Suicide and Borderline Personality Disorder that has completed, run by University of Washington. The registered enrollment target is 99 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00183651, a Phase 2 study of Suicide and Borderline Personality Disorder, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a component analysis of dialectical behavior therapy (DBT) to determine the importance of DBT skills training and DBT individual therapy in treating suicidal women with borderline personality disorder.
Conditions Studied
Interventions
- BEHAVIORAL Standard dialectical behavior therapy (SDBT)
- BEHAVIORAL Individual DBT with no DBT group sessions (DBT-I)
- BEHAVIORAL Group Skills DBT with no DBT individual sessions (DBT-S)
Study Locations (1)
Washington
- University of Washington, Department of Psychology, Behavior Research and Therapy Clinics - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2004-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183651
The ClinicalTrials.gov registry entry for NCT00183651 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 3 interventions - of which Standard dialectical behavior therapy (SDBT) is the first listed.
NCT00183651 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00183651 about?
NCT00183651 is a clinical study titled "Treatment of Suicidal Women With Borderline Personality Disorder". This study is a component analysis of dialectical behavior therapy (DBT) to determine the importance of DBT skills training and DBT individual therapy in treating suicidal women with borderline personality disorder.
What is the current status of trial NCT00183651?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 99 participants. The study started on 2004-04. Estimated completion is 2010-06.
What conditions does trial NCT00183651 study?
This clinical trial studies the following conditions: Suicide, Borderline Personality Disorder.
What interventions are being tested in trial NCT00183651?
The interventions under investigation include: Standard dialectical behavior therapy (SDBT) (BEHAVIORAL), Individual DBT with no DBT group sessions (DBT-I) (BEHAVIORAL), Group Skills DBT with no DBT individual sessions (DBT-S) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183651?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183651 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suicide Risk Interventions
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
RECRUITING · Phase 2
-
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
RECRUITING · Phase 2
-
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
RECRUITING · Phase 2
-
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.